Rabbit CPT2 Polyclonal Antibody | anti-CPT2 antibody

Anti-CPT2 Antibody

Cat. Num. AAA4150175

• Gene Names: CPT2; CPT1; IIAE4; CPTASE
• Reactivity: Human, Mouse, Rat
• Applications: Western Blot, Immunohistochemistry, Immunofluorescence
• Purity: Affinity Purification
• Synonyms: CPT2; Polyclonal Antibody; Anti-CPT2 Antibody; anti-CPT2 antibody

• Host: Rabbit
• Reactivity: Human, Mouse, Rat
• Clonality: Polyclonal
• Isotype: IgG
• Specificity: Western blot analysis of extracts of Mouse fetal kidney tissue lysate, using CPT2 antibody. Immunohistochemistry of paraffin-embedded human esophagus cancer tissue using CPT2 antibody. Immunofluorescence analysis of MCF7 cell using CPT2 antibody. Blue: DAPI for nuclear staining.
• Purity/Purification: Affinity Purification
• Form/Format: Liquid
• Concentration: 1mg/ml (varies by lot)
• Sequence Length: 635

• Applicable Applications for anti-CPT2 antibody: Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
• Application Notes: WB: 1:500 - 1:2000; IHC: 1:50-1:100; IF: 1:50-1:100
• Immunogen: A synthetic peptide of human CPT2
• Storage Buffer: PBS with 0.02% sodium azide,50% glycerol, pH7.3.
• Preparation and Storage: Store at -20 degree C (regular) and -80 degree C (long term). Avoid freeze / thaw cycles.

Immunohistochemistry (IHC)

Immunofluorescence (IF)

Related Product Information for anti-CPT2 antibody

The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders.

NCBI and Uniprot Product Information

• NCBI GI #: 1060099013
• NCBI GeneID: 1376
• NCBI Accession #: NP_001317518.1
• NCBI GenBank Nucleotide #: NM_001330589.1
• Molecular Weight: 73,777 Da
• NCBI Official Full Name: carnitine O-palmitoyltransferase 2, mitochondrial isoform 2
• NCBI Official Synonym Full Names: carnitine palmitoyltransferase 2
• NCBI Official Symbol: CPT2
• NCBI Official Synonym Symbols: CPT1; IIAE4; CPTASE
• NCBI Protein Information: carnitine O-palmitoyltransferase 2, mitochondrial
• UniProt Protein Name: Carnitine O-palmitoyltransferase 2, mitochondrial
• Protein Family: Carnitine O-palmitoyltransferase
• UniProt Gene Name: CPT2
• UniProt Synonym Gene Names: CPT1; CPT II

NCBI Description

The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders. [provided by RefSeq, Jul 2008]

Uniprot Description

CPT2: Defects in CPT2 are the cause of carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D); also known as CPT-II deficiency or CPT2 deficiency. CPT2D is an autosomal recessive disorder characterized by recurrent myoglobinuria, episodes of muscle pain, stiffness, and rhabdomyolysis. These symptoms are triggered by prolonged exercise, fasting or viral infection and patients are usually young adults. In addition to this classical, late-onset, muscular type, a hepatic or hepatocardiomuscular form has been reported in infants. Clinical pictures in these children or neonates include hypoketotic hypoglycemia, liver dysfunction, cardiomyopathy and sudden death. Defects in CPT2 are the cause of carnitine palmitoyltransferase 2 deficiency infantile (CPT2DI). A disorder of mitochondrial long-chain fatty acid oxidation characterized by hepatic or hepato-cardio-muscular manifestations with onset in infancy. Clinical features include hypoketotic hypoglycemia, lethargy, seizures, hepatomegaly, liver dysfunction, cardiomegaly and dilated cardiomyopathy. Defects in CPT2 are the cause of carnitine palmitoyltransferase 2 deficiency lethal neonatal (CPT2D-LN); also known as lethal neonatal CPT-II deficiency. It is a lethal neonatal form of CPT2D. This rarely presentation is antenatal with cerebral periventricular cysts and cystic dysplastic kidneys. The clinical variability of the disease is likely attributed to the variable residual enzymatic activity. Defects in CPT2 are a cause of susceptibility to encephalopathy acute infection-induced type 4 (IIAE4). A severe neurologic complication of an infection. It manifests within days in otherwise healthy children after common viral infections, without evidence of viral infection of the brain or inflammatory cell infiltration. In affected children, high- grade fever is accompanied within 12 to 48 hours by febrile convulsions, often leading to coma, multiple-organ failure, brain edema, and high morbidity and mortality. The infections are usually viral, particularly influenza, although other viruses and even mycoplasma have been found to cause the disorder. Polymorphic variants in CPT2 can confer susceptibility to infection-induced encepalopathy. These variants do not cause classical carnitine palmitoyltransferase 2 deficiency, and patients harboring any of them are asymptomatic most of the time. However, they are prone to viral infection (high fever)-related encephalopathy (PubMed:21697855). Belongs to the carnitine/choline acetyltransferase family.

Protein type: EC 2.3.1.21; Lipid Metabolism - fatty acid; Mitochondrial; Transferase

Chromosomal Location of Human Ortholog: 1p32.3

Cellular Component: mitochondrial inner membrane; mitochondrion; nucleolus; nucleoplasm

Molecular Function: carnitine O-palmitoyltransferase activity

Biological Process: carnitine shuttle

Disease: Carnitine Palmitoyltransferase Ii Deficiency, Infantile; Carnitine Palmitoyltransferase Ii Deficiency, Late-onset; Carnitine Palmitoyltransferase Ii Deficiency, Lethal Neonatal; Encephalopathy, Acute, Infection-induced, Susceptibility To, 4